Author: Ingels, Alexandre; Bibas, Steeven; Abdessater, Maher; Tabourin, Thomas; Roupret, Morgan; Chartierâ€Kastler, Emmanuel; Barker, Gwendolyn; Tobbal, Nouha; Doizi, Steeve; Cussenot, Olivier; Prost, Doriane; Desgrandchamps, Francois; Ouzaid, Idir; Rollin, Paul; Hermieu, Jeanâ€Francois; Audenet, Francois; Userovici, Mickael; Mejean, Arnaud; Anract, Julien; Roux, Sabine; Peyromaure, Michael; Couteau, Nicolas; Lebacle, Cédric; Irani, Jacques; Vordos, Dimitri; Yiou, René; Hoznek, Andras; Champy, Cecile M; Da Costa, Jose Batista; De La Taille, Alexandre
Title: Urology surgical activity and COVIDâ€19: Risk assessment at the epidemic peak the parisian multicenter experience Cord-id: 1nu8trfv Document date: 2020_7_8
ID: 1nu8trfv
Snippet: OBJECTIVES: To evaluate the risk of contracting severe COVIDâ€19, defined as COVIDâ€19 specific intensive care unit (ICU) admission or death, for patients undergoing urological surgery during the epidemic. To define consequences of receiving surgery for COVIDâ€19 patients. PATIENTS AND METHODS: This is a multicenter observational cohort study. Every patient receiving a urological procedure in Paris academic urological centers during the 4 initial weeks of surgical restrictions were included.
Document: OBJECTIVES: To evaluate the risk of contracting severe COVIDâ€19, defined as COVIDâ€19 specific intensive care unit (ICU) admission or death, for patients undergoing urological surgery during the epidemic. To define consequences of receiving surgery for COVIDâ€19 patients. PATIENTS AND METHODS: This is a multicenter observational cohort study. Every patient receiving a urological procedure in Paris academic urological centers during the 4 initial weeks of surgical restrictions were included. Their status was updated minimum 3 weeks after the procedure. The main outcomes were the COVIDâ€19 specific ICU admission and death. Statistics were mostly descriptive. The Postâ€operative COVIDâ€19 confirmed group was compared with nonâ€COVID patients using Chiâ€square tests for categorical and Wilcoxon test tests for continuous variables. RESULTS: During the 4â€week period, 552 patients received surgery within 8 centers. At followâ€up, 57 (10%) patients were lost. Among the 11 preoperative COVIDâ€19 cases, one remained in ICU, no new admission, and no death. For the nonâ€COVID patients, 57 (12%) developed COVIDâ€related symptoms; only one case (0.2%) required COVIDâ€19 specific ICU and 3 (0.6%) patients died of COVIDâ€19 after surgery. CONCLUSIONS: Performing urological surgery during the COVIDâ€19 epidemic peak has a limited impact on ICU admissions but presents a real (0.6%) risk of specific mortality. Surgical activities should be maintained according to this risk.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date